Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre clinical trials
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre is the lead sponsor of 3 current clinical trials in our EU (CTIS) register. The drugs named most often in its trials are Semaglutide and Tirzepatide.
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre in the EU trials register (CTIS)
3 trialsAuthorised or ongoing trials in the EU Clinical Trials Information System with Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre as sponsor. Some are the same study as a ClinicalTrials.gov record above; the two registries share no common ID. Trials with a site in Ireland are listed first.
| Study | Phase | Status | Countries |
|---|---|---|---|
|
ObStructive Sleep Apnoea ManageMent in Older AdUlts with Overweight or ObEsity: A Randomized ClinicaL Trial (SAMUEL study)
2026-525500-10-00 · Nutritional and Metabolic Diseases
Drug: Tirzepatide |
Phase 4 | Authorised | Spain |
|
Evaluation of the Non-Inferiority of Topical Chloramphenicol Versus Topical Ciprofloxacin in the Resolution of Otorrhea in Adults With Chronic Suppurative Otitis Media (CSOM) – Protocol OMCOS
2026-525540-15-00 · CTIS ↗ · Otorhinolaryngologic Diseases
|
Phase 3 | Authorised | Spain |
|
TheRapeutic StrAtegies for Obstructive SleeP Apnea in Older Adults with OverweigHt or Obesity: A RandomizEd Clinical TriaL (RAPHAEL study)
2025-524819-37-00 · CTIS ↗ · Respiratory Tract Diseases
Drug: Semaglutide |
Phase 4 | Authorised | Spain |
Drugs in Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre trials
2 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
By trial register
| Register | Trials | Recruiting |
|---|---|---|
| EU register (CTIS) | 3 | — |
A trial with sites in more than one country appears in each of those registers.
Questions about Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre trials
How many clinical trials does Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre sponsor?
Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre is the lead sponsor of 3 authorised or ongoing trials in the EU register (CTIS), as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Which drugs is Institut De Recerca Biomedica De Lleida Fundacio Dr. Pifarre testing?
Its current trials name 2 drugs and biologicals as interventions. The most frequent are Semaglutide (1) and Tirzepatide (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.